C24H30Cl2F2O6
Neat
523.39
23961-24-2; Halometasone Impurity 1; Halometasone Impurity 12; 2-((6S, 8S, 9R, 10S, 11S, 13S, 14S, 16R, 17R)-1, 2-dichloro-6, 9-difluoro-11, 17-dihydroxy-10, 13, 16-trimethyl-3-oxo-2, 3, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate
[2-[(6S, 8S, 9R, 10S, 11S, 13S, 14S, 16R, 17R)-1, 2-dichloro-6, 9-difluoro-11, 17-dihydroxy-10, 13, 16-trimethyl-3-oxo-1, 2, 6, 7, 8, 11, 12, 14, 15 and 16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
InChI=1S/C24H30Cl2F2O6/c1-10-5-12-13-6-15(27)14-7-16(30)19(25)20(26)22(14,4)23(13,28)17(31)8-21(12,3)24(10,33)18(32)9-34-11(2)29/h7,10,12-13,15,17,19-20,31,33H,5-6,8-9H2,1-4H3/t10-,12+,13+,15+,17+,19?,20?,21+,22-,23+,24+/m1/s1